Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis
MENACTRIMS Research Grant
As part of MENACTRIMS’s commitment to support and expand MS research across the Middle East & North Africa region, we will fund two MENACTRIMS Research Grants per year.
Submit Now »
MENACTRIMS is an independent organization that facilitates communication and creates synergies among clinicians and scientists to promote and enhance research and improve clinical outcomes in multiple sclerosis (MS).
Multiple Sclerosis (MS) is a chronic demyelinating disorder of the central nervous system (CNS) that affects predominately patients aged 20-40 years.